← SynDRA
methylnorlichexanthone
SynDRA canonical compound SYN0086713 — structure-anchored drug synonym record
| Primary target(s) | AURKB |
| Mechanism of action | Aurora kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- VEGFR inhibitor
- Pim kinase inhibitor
- aurora kinase inhibitor
Cross-references
Synonyms
- 1,3-Dihydroxy-6-methoxy-8-methyl-9-xanthenone
- 1,3-dihydroxy-6-methoxy-8-methylxanthen-9-one
- SPBio_001783
- Spectrum_000552
- SpecPlus_000108
- Spectrum2_001802
- Spectrum3_001285
- Spectrum4_001590
- Spectrum5_000280
- BSPBio_002889
- KBioGR_002180
- KBioSS_001032
- DivK1c_006204
- Xanthen-9-one, 1,3-dihydroxy-6-methoxy-8-methyl-
- 9H-Xanthen-9-one, 1,3-dihydroxy-6-methoxy-8-methyl-
- CHEBI:92577
- KBio1_001148
- KBio2_001032
- KBio2_003600
- KBio2_006168
- KBio3_002109
- RFENQGQGMLPVJM-UHFFFAOYSA-N
- CCG-38448
- NCGC00178407-01
- 1,3-dihydroxy-6-methoxy-8-methyl-xanthen-9-one
- BRD-K33193182-001-02-5
- 1,3-Dihydroxy-6-methoxy-8-methyl-9H-xanthen-9-one #
- 1,3-dihydroxy-6-methoxy-8-methyl-9-xanthenone
- 6-O-methylnorlichexanthone
Look up methylnorlichexanthone in the interactive SynDRA portal →